Overview

Early Oseltamivir Treatment of Influenza in Children 1-3 Years of Age

Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The main purpose of this study is to assess the efficacy of early oseltamivir treatment (started within 24 hours of the onset of influenza symptoms) in preventing the development of acute otitis media as a complication of influenza in children aged 1-3 years.
Phase:
Phase 4
Details
Lead Sponsor:
Hospital District of Southwestern Finland
Collaborator:
Hoffmann-La Roche
Treatments:
Oseltamivir